Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Clin Chim Acta. 2008 Jun;392(1-2):21-4. doi: 10.1016/j.cca.2008.02.018. Epub 2008 Feb 25.

Abstract

Background: Deep vein thrombosis is a condition, which has several acquired as well as genetic causes. One of the most common reasons for deep vein thrombosis is activated protein C resistance caused by Factor V Leiden.

Method: We examined the risk posed by Factor V Leiden, Hong Kong/Cambridge and HR2 Haplotype mutations in 155 deep vein thrombosis patients and 120 healthy controls in the background of activated protein C resistance.

Result: Thirty-one of our patients showed activated protein C resistance of which only 16 carried Factor V Leiden mutation which was a far lower number than what is usually seen in Caucasian population. Factor V Leiden mutation was significantly associated with the risk of deep vein thrombosis (Yates corrected p-value=0.002; 95%CI; odds ratio: 13.7). Factor V Hong Kong/Cambridge and HR2 Haplotype were not found to be associated with the risk of deep vein thrombosis. There is a possibility that Factor V HR2 Haplotype might also be associated with activated protein C resistance even in the absence of Factor V Leiden.

Conclusions: Factor V Leiden mutation was seen to contribute far less towards activated protein C resistance in Asian-Indian deep vein thrombosis patients than what has been commonly observed in Caucasians.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activated Protein C Resistance / blood*
  • Adolescent
  • Adult
  • Asian People / genetics*
  • Child
  • Child, Preschool
  • Factor V / genetics*
  • Factor V / metabolism
  • Genotype
  • Humans
  • India
  • Middle Aged
  • Mutation
  • Venous Thrombosis / blood*
  • Venous Thrombosis / genetics*

Substances

  • factor V Hong Kong
  • factor V Leiden
  • Factor V